EN
English
Anoro Ellipta 20 mcg
Added to your cart
59
TWINRIX
Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine
EN
English
Anoro Ellipta 20 mcg
Added to your cart
59
Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine
Popular holiday destinations such as the Caribbean have been identified as hepatitis A and B risk areas for unprotected travellers 9, 10
According to the Canadian Immunization Guide, people who travel outside of Canada are at increased risk for hepatitis A and B infections. 4, 8
Countries or areas with moderate to high risk for hepatitis A 9
Travellers may contract hepatitis A via: 4, 11, 12
Hepatitis A virus can survive up to 10 months in water and on dried surfaces for 7 days. 1
Countries or areas with moderate to high risk for hepatitis B 10
Travellers may contract hepatitis B via: 7, 8
Hepatitis B can survive on surfaces for at least 7 days and still be capable of causing infection. 1
Hepatitis B is a risk for Canadian travellers
Hepatitis A and B are two of the most common vaccine-preventable diseases in travellers 4, 8
TWINRIX combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine is indicated for active immunization against hepatitis A and hepatitis B virus infection in adults, adolescents, children and infants. 1
TWINRIX will not protect against infection caused by other agents such as hepatitis C, hepatitis E and other pathogens known to infect the liver. It can be expected that hepatitis D will also be prevented by immunization with TWINRIX as hepatitis D (caused by the delta agent) does not occur in the absence of hepatitis B infection. 1
1. TWINRIX Product Monograph. November 2023.
4. Public Health Agency of Canada. Canadian Immunization Guide - Part 4. 2018. (CIG) Available at https://www.canada.ca/en/public-health/services/canadian-immunization-guide.html.
7. Centers for Disease Control and Prevention. Hepatitis B FAQ for Health Professionals. Available at https://www.cdc.gov/hepatitis/hbv/hbvfaq.htm#treatment
8. Public Health Agency of Canada. Canada Communicable Disease Report, Statement on Hepatitis Vaccines for Travellers. July 2008, Vol.34, ACS-2. (CATMAT) Available at www.phac-aspc.gc.ca/publicat/ccdr-rmtc/08vol34/acs-2/index-eng.php
9. World Health Organization. Hepatitis A, countries or areas at risk. http://gamapserver.who.int/mapLibrary/Files/Maps/Global_Hepa_ITHRiskMap.png
10. World Health Organization. Hepatitis B, countries or areas at risk. Available at http://gamapserver.who.int/mapLibrary/Files/Maps/Global_Hepb_ITHRiskMap.png
11. Centers for Disease Control and Prevention. Hepatitis A Questions and Answers for Health Professionals. Available at https://www.cdc.gov/hepatitis/hbv/hbvfaq.htm#overview
12. Centers for Disease Control and Prevention. Yellow Book 2016. Available at http://wwwnc.cdc.gov/travel/yellowbook/2016/infectious-diseases-related-to-travel/hepatitis-a
This page is for Healthcare Professionals only. If you are not a Healthcare Professional, please visit Twinrix.ca.